SMC Spain

According to a meta-analysis of 14 studies involving more than 25,000 people, drinking more than four cups of coffee per day was associated with a lower incidence of head and neck tumors. Drinking between none and one cup of tea was also associated with a slightly decreased risk, although daily consumption of more than one cup of tea was associated with an increased risk of developing laryngeal cancer. The results are published in the journal Cancer. 

A team in the US has for the first time achieved quantum teleportation over 30 kilometres of fibre-optic cable already carrying internet data traffic, says a study published in the journal Optica. This type of teleportation would allow quantum communication to be combined with existing internet cable infrastructure. 

Meeting in the city of Windoek (Namibia), the plenary of the IPBES - Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services - has ratified two new reports: the Nexus Assessment and the Transformative Change Assessment. Three of their authors explained the main findings and the changes they propose at a briefing organised by SMC Spain.

In a group of people at high cardiovascular risk, low to moderate wine consumption was associated with fewer cardiovascular events (cardiovascular death, myocardial infarction, stroke or heart failure), according to a study. The analysis uses urinary concentrations of tartaric acid, a substance found in grapes and grape derivatives, as a biomarker of wine consumption. It finds that consuming between three and 35 glasses per month was associated with fewer cardiovascular events than in people who consumed fewer than three or more than 35 glasses. The study, published in the European Heart Journal, included more than 1,200 participants from Spain's PREDIMED study with an average age of 68 years.

A meta-analysis published in The Lancet Psychiatry compared various pharmacological and non-pharmacological treatments for Attention Deficit Hyperactivity Disorder (ADHD) in adults. The authors found that only stimulants and atomoxetine effectively reduce symptoms after 12 weeks, but warn that the drugs are not well tolerated by everyone, that they found no evidence that they improve quality of life and that their long-term effects are unclear.

In 2015, the human health impact of exposure to certain chemicals cost the equivalent of $1.5 trillion, says a study published in PNAS. The study estimates cases of ischaemic heart disease and stroke associated with bisphenol A (BPA) exposure; deaths of 55-64 year olds associated with di(2-ethylhexyl) phthalate (DEHP) exposure; and cognitive losses in children of mothers exposed to brominated flame retardants (PBDEs).

Thirty eight scientists from different specialties, including Craig Venter, a pioneer in the creation of artificial synthetic life, have written an article in the journal Science in which they assess the possibilities of synthesizing mirror organisms, but also warn of the risks they pose. This type of microorganisms, which would present a mirror structure to that currently found in nature, would have potential applications due to their resistance to biological degradation. However, they would also pose a danger because they would not be recognized by our defenses and could spread in ecosystems. Scientists call for more research and a broad debate, and warn that until more is known, this type of organism should not be created. 

A team of researchers has analyzed more than 300 human genomes from the last 50,000 years and has concluded that most of the gene flow we received from Neanderthals is attributable to a single period, which probably occurred between 50,500 and 43,500 years ago. In addition, Neanderthal inheritance underwent rapid natural selection in subsequent generations, especially on the X chromosome, according to a study published in Science.

Science magazine has named lenacapavir as breakthrough of the year. Lenacapavir is an injectable drug that prevents HIV infection for six months with near 100% efficacy. The publication notes its potential to dramatically reduce infections in high-risk populations, but also reminds that global roll-out will depend on affordability, manufacturing agreements and a robust health infrastructure. Approval of the drug is expected by 2025. 

A team of researchers has analyzed data from the World Health Organization to estimate the incidence of colorectal cancer in 50 countries around the world. Their conclusions, based on records up to 2017, are that in most high-income countries its incidence continues to increase in young people (under 50 years of age). This increase, however, is not observed in Spain. The results are published in the journal The Lancet Oncology.